Demand for weight-loss drugs is rising at a fast clip in India, where rivals Eli Lilly and Novo Nordisk are competing for ...

Explore the implications of GLP-1 drugs in managing India's obesity crisis as experts warn of potential misuse and health ...

Incidence of obesity and diabetes is rising in India, the world's most populous country, which also ranks among the worst ...

NEW DELHI – India is witnessing a sharp rise in the demand for obesity and diabetes medications, with urban populations ...

Cipla is set to enter India's weight management market, addressing the increasing demand for obesity solutions, while also ...

Eli LillyDemand for weight-loss drugs in India has shot up.And rivals Novo Nordisk and Eli Lilly are battling for market ...

India's demand for weight-loss drugs is surging, with Eli Lilly's Mounjaro and Novo Nordisk's Wegovy competing for dominance. The obesity drug market has grown fivefold since 2021, driven by ...

Health news highlights the booming demand for obesity drugs in India with companies like Eli Lilly and Novo Nordisk vying for ...

India's Rs 628-crore anti-obesity market sees heightened competition as Wegovy and Mounjaro post strong sales amid rising ...

Big pharma’s slim chance: Obesity drug demand soars in India as Lilly, Novo jostle for market supremacy Sales of Eli Lilly’s Mounjaro double in a month; Novo Nordisk’s Wegovy enters market ...